$ECVT earnings report

Ecovyst Reports Third Quarter 2026 Results and Raises 2026 Outlook. AlphAI read Ecovyst's Third Quarter 2026 filing as solid.

Third Quarter 2026

AlphAI · Earnings readECVT · Third Quarter 2026 · ended September 30, 2026

Ecovyst Reports Third Quarter 2026 Results and Raises 2026 Outlook

✓Solid quarter

Third-quarter sales increased 50.6% and Adjusted EBITDA increased 6.4%, while the Company raised its 2026 sales, Adjusted EBITDA and Adjusted Free Cash Flow outlooks. The reported Adjusted EBITDA margin declined to 19.8% from 28.1%, and debt increased following the Calabrian acquisition.

EPS · non-GAAP
$0.23
2026 outlook
$1,050 million to $1,070 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Sales, three months ended September 30, 2026GAAP$308.6M–50.6%
Cost of goods sold, three months ended September 30, 2026GAAP$249.9M–63.5%
Gross profit, three months ended September 30, 2026GAAP$58.7M–12.7%
Selling, general and administrative expenses, three months ended September 30, 2026GAAP$20.4M–29.9%
Other operating expense, net, three months ended September 30, 2026GAAP$9.1M–12.3%
Operating income, three months ended September 30, 2026GAAP$29.2M–3.2%
Interest expense, net, three months ended September 30, 2026GAAP$6.2M–(27.9)%
Income from continuing operations before income taxes, three months ended September 30, 2026GAAP$22.9M–12.3%
Provision for income taxes, three months ended September 30, 2026GAAP$4.5M–(77.7)%
Effective tax rate, three months ended September 30, 2026GAAP19.9%––
Net income from continuing operations, three months ended September 30, 2026GAAP$18.4M–NM
Net loss from discontinued operations, net of tax, three months ended September 30, 2026GAAP−$200K–(99.7)%
Net income, three months ended September 30, 2026GAAP$18.2M–123.0%
Diluted income per share from continuing operations, three months ended September 30, 2026GAAP$0.17––
Diluted income per share, three months ended September 30, 2026GAAP$0.16––
Adjusted EBITDA from continuing operations, three months ended September 30, 2026non-GAAP$61.2M–6.4%
Adjusted EBITDA from continuing operations margin, three months ended September 30, 2026non-GAAP19.8%––
Adjusted Net Income, three months ended September 30, 2026non-GAAP$25.3M––
Adjusted Diluted Income per share, three months ended September 30, 2026non-GAAP$0.23––
Sales, nine months ended September 30, 2026GAAP$773.6M–47.6%
Gross profit, nine months ended September 30, 2026GAAP$145M–30.2%
Operating income, nine months ended September 30, 2026GAAP$61.1M–41.8%
Net income from continuing operations, nine months ended September 30, 2026GAAP$34.8M–NM
Net income, nine months ended September 30, 2026GAAP$30.3M–139.4%
Diluted income per share from continuing operations, nine months ended September 30, 2026GAAP$0.31––
Diluted income per share, nine months ended September 30, 2026GAAP$0.27––
Adjusted EBITDA from continuing operations, nine months ended September 30, 2026non-GAAP$154.2M–27.8%
Adjusted EBITDA from continuing operations margin, nine months ended September 30, 2026non-GAAP19.9%––
Adjusted Net Income, nine months ended September 30, 2026non-GAAP$61M––
Adjusted Diluted Income per share, nine months ended September 30, 2026non-GAAP$0.55––
Net cash provided by operating activities, continuing operations, nine months ended September 30, 2026GAAP$80.7M––
Net cash provided by operating activities, nine months ended September 30, 2026GAAP$76.5M––
Purchases of property, plant and equipment, nine months ended September 30, 2026GAAP−$72.7M––
Free Cash Flow, nine months ended September 30, 2026non-GAAP$3.8M––
Adjusted Free Cash Flow, nine months ended September 30, 2026non-GAAP$32.4M––
Cash and cash equivalents, September 30, 2026GAAP$71.2M––
Total debt, September 30, 2026other$497.1M––
Net debt, September 30, 2026non-GAAP$425.9M––
Net Debt Leverage Ratio, September 30, 2026non-GAAP2.1x––
Net Debt to Net Income Ratio, September 30, 2026non-GAAP9.7x––

2026 outlook

  • Revenue$1,050 million to $1,070 million
  • Tax ratemid 20% range
  • NoteAdjusted EBITDA of approximately $208 million to $212 million, including an impact from Calabrian in the fourth quarter of $5 million to $6 million
  • NoteAdjusted Free Cash Flow of $50 million to $60 million
  • NoteCapital expenditures of $90 million to $95 million
  • NoteInterest expense of $19 million to $21 million
  • NoteDepreciation & Amortization of $84 million to $88 million
  • NoteAdjusted Net Income of $70 million to $85 million
  • NoteAdjusted Diluted Income per share of $0.63 to $0.77
  • NoteSales outlook assumes higher average sulfur prices compared to 2025 and higher projected pass-through of sulfur costs of approximately $220 million

Capital returns

  • During the third quarter of 2026, the Company repurchased 263,719 shares of its common stock on the open market at an average price of $10.25 per share, for a total cost of $2.7 million.
  • As of September 30, 2026, $143.8 million was available for stock repurchases under the program.
  • The Company intends to repurchase up to a total of $20 million in the second half of 2026.

What drove it

  • Higher sales volume and pricing, together with results from the Calabrian business acquired June 30, 2026, drove sales growth.
  • Average selling prices were higher primarily due to the pass-through effect of higher sulfur costs of approximately $67 million and favorable contractual pricing for regenerated sulfuric acid.
  • Higher regenerated sulfuric acid sales reflected strong demand and less customer downtime.
  • Virgin sulfuric acid sales benefited from solid mining demand, stable industrial-application demand and positive pricing fundamentals.
  • Adjusted EBITDA growth reflected higher sales volume and favorable net pricing.

Concerns

  • Adjusted EBITDA from continuing operations margin was 19.8% in the third quarter of 2026 compared with 28.1% in the third quarter of 2025.
  • Higher manufacturing costs, general inflation and higher transportation costs partially offset higher sales volume and favorable net pricing.
  • The Company remains cautious about potential unplanned outages with refining customers.
  • A significant decrease in the price of sulfur could drive short-term customer destocking.
  • The Net Debt Leverage Ratio increased from 1.2x at December 31, 2025 to 2.1x at September 30, 2026, due to the $100 million increase in the term loan associated with the Calabrian acquisition and only one quarter of Calabrian-related Adjusted EBITDA in the trailing twelve-month period.

What to watch

  • High refinery utilization and strong alkylate demand as supports for regenerated sulfuric acid sales through year-end.
  • Demand growth for copper mining applications and Canadian gold mine operating rates as supports for virgin sulfuric acid and Calabrian sulfur dioxide sales.
  • Calabrian integration progress and anticipated synergy capture.
  • The fourth-quarter contribution from Calabrian of $5 million to $6 million within Adjusted EBITDA guidance.
  • The shift of a turnaround from the fourth quarter into early 2027.

Balance sheet and cash flow

  • Cash and cash equivalents were $71.2 million as of September 30, 2026.
  • Total gross debt was $497.1 million and availability under the ABL facility was $95.8 million, after giving effect to $2.2 million of outstanding letters of credit and with no revolving credit facility borrowings outstanding.
  • Total available liquidity was $167.0 million as of September 30, 2026.
  • Net cash used in investing activities was $(262.4) million for the nine months ended September 30, 2026, including $178.5 million of business combinations.
  • Net cash provided by financing activities was $60.2 million for the nine months ended September 30, 2026, including $100.0 million of issuance of long-term debt, net of original issue discount and financing fees.

Analysis

Ecovyst reported third-quarter sales of $308.6 million, up 50.6% from $204.9 million, while Adjusted EBITDA from continuing operations increased 6.4% to $61.2 million. Revenue growth reflected higher volume and pricing, including the pass-through effect of higher sulfur costs of approximately $67 million, favorable regenerated sulfuric acid contractual pricing, and the first full quarter of ownership of Calabrian. Regenerated sulfuric acid demand benefited from strong demand and less customer downtime, while virgin sulfuric acid demand was supported by mining and industrial applications.

The growth conversion to earnings was more modest than sales growth. Gross profit increased 12.7% to $58.7 million and operating income increased 3.2% to $29.2 million. Adjusted EBITDA margin was 19.8%, compared with 28.1% in the year-ago quarter. Ecovyst attributed the partial offset to higher manufacturing costs, general inflation and higher transportation costs. GAAP net income from continuing operations was $18.4 million, compared with $0.2 million, aided by a $4.5 million income-tax provision versus $20.2 million in the prior-year quarter.

For the nine months, continuing-operations operating cash flow increased to $80.7 million from $77.0 million, but Adjusted Free Cash Flow declined to $32.4 million from $42.4 million. The Company spent $72.7 million on purchases of property, plant and equipment and $178.5 million on business combinations. Cash and cash equivalents were $71.2 million, total debt was $497.1 million, and net debt was $425.9 million at September 30, 2026. The Net Debt Leverage Ratio was 2.1x, compared with 1.2x at December 31, 2025.

Capital allocation included $2.7 million of third-quarter open-market repurchases, with $143.8 million remaining under the authorization and an intent to repurchase up to a total of $20 million in the second half of 2026. The Company raised 2026 sales guidance to $1,050 million to $1,070 million, Adjusted EBITDA guidance to approximately $208 million to $212 million, and Adjusted Free Cash Flow guidance to $50 million to $60 million. Management cited strong first-nine-month performance and a turnaround shifting from the fourth quarter into early 2027, while identifying refinery outages and potential sulfur-price-related customer destocking as risks.

Management, verbatim

Ecovyst delivered another strong quarter, with third quarter 2026 Adjusted EBITDA of $61 million, up over 6% compared to the year-ago quarter, and above the high end of our guidance range.

Kurt J. Bitting, Chief Executive Officer

Given current refining economics, we anticipate high refinery utilization through year-end and we expect demand across our portfolio to remain healthy for the rest of the year.

Kurt J. Bitting, Chief Executive Officer

We remain flexible in how we allocate capital while prioritizing stockholder value.

Kurt J. Bitting, Chief Executive Officer

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • No revenue or profit breakout by operating segment was reported.
  • Quarterly operating cash flow, free cash flow and capital expenditures were not reported.
  • Dividend information was not reported.
  • No previous earnings release outlook was provided for formal actual-versus-prior-guidance comparisons.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about ECVT earnings dates

When is Ecovyst's next earnings date?
AlphAI has no date for ECVT yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.